Checked.be
Active
BE 0534.614.708Private limited company
SONUWE
Beringersteenweg 103 ·3520 Zonhoven, Belgium· 13 yrs active
Sector: Veterinary services
(75000)
Conclusion
SONUWE has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €205k and a net result of €14k. Equity is growing by ~12.9% per year across the filed fiscal years. Its solvency ranks better than 86% of 232 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €205k |
| Net result | €14k |
| Staff (FTE) | 2.2 |
| Better than sector | 86% |
Financial profile
74
/ 100
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Health
86
Profitability
34
Solvency
100
Growth
52
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2013, 13 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
86
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€18k
estimate, not credit advice
Score history
93
2021
86
2022
100
2023
86
2024
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 4.03 (≥ 1.5)
+10
Quick ratio
Quick ratio 2.71 (≥ 1.0)
+5
Leverage
Debt/equity 0.26 (< 1.0)
+10
Profitability
ROE 7%
+3
Interest coverage
Interest coverage 124.3× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 13-06-2025 with the NBB · fiscal year 2024 · abbreviated schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~12.9%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 75, Veterinary activities · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 79.7% | 42.1% | |
| Net result | €14k | €68k | |
| Equity | €205k | €207k | |
| Gross operating margin | €159k | €181k | |
| Staff costs | €106k | €83k |
€50k
-35.5%
21-24
€14k
-56.5%
21-24
€42k
-29.9%
21-24
€257k
-1.6%
21-24
€205k
+7.4%
21-24
€145k
+19.0%
21-24
2
+83.3%
21-24
€106k
+142.9%
21-24
€8k
-54.7%
21-24
€52k
-26.0%
21-24
€48k
-17.9%
21-24
€4k
-64.1%
21-24
4.03
+30.3%
21-24
2.71
+17.0%
21-24
79.7%
+9.2%
21-24
0.26
-31.1%
21-24
6.9%
-59.5%
21-24
5.5%
-55.8%
21-24
124.33
-27.5%
21-24
Figures by fiscal year and ratios
| Fiscal year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | - | - | - | - |
| EBITDA | €50k | €78k | €47k | €68k |
| Net profit | €14k | €32k | €13k | €30k |
| Cash flow | €42k | €60k | €41k | €57k |
| Staff costs | €106k | €44k | €28k | €22k |
| Income taxes | €8k | €18k | €6k | €11k |
| Dividends | - | - | - | - |
| Total assets | €257k | €261k | €252k | €218k |
| Equity | €205k | €191k | €158k | €146k |
| Debt | €52k | €71k | €94k | €72k |
| of which ≤ 1y | €48k | €58k | €74k | €45k |
| of which > 1y | €4k | €12k | €20k | €27k |
| Working capital | €145k | €122k | €86k | €69k |
| Employees (FTE) | 2.2 | 1.2 | 0.8 | 0.7 |
Ratios (computed)
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Current ratio | 4.03 | 3.09 | 2.16 | 2.55 |
| Quick ratio | 2.71 | 2.32 | 1.68 | 1.69 |
| Working capital ratio | 56.4% | 46.6% | 34.1% | 31.8% |
| Solvency | 79.7% | 73.0% | 62.7% | 66.8% |
| Debt / equity | 0.26 | 0.37 | 0.59 | 0.50 |
| Long-term debt ratio | 0.02 | 0.06 | 0.13 | 0.19 |
| Interest coverage | 124.33 | 171.57 | 81.56 | 125.12 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 5.5% | 12.4% | 5.0% | 13.9% |
| ROE | 6.9% | 17.0% | 8.0% | 20.7% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2024
Full annual accounts (24 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €257k | €261k | €252k | €218k |
| Fixed assets | 21/28 | €64k | €81k | €92k | €104k |
| Intangible fixed assets | 21 | €15k | €30k | €44k | €58k |
| Tangible fixed assets | 22/27 | €49k | €52k | €49k | €46k |
| Current assets | 29/58 | €193k | €180k | €160k | €114k |
| Stocks & contracts in progress | 3 | €63k | €45k | €36k | €38k |
| Amounts receivable within one year | 40/41 | €14k | €9k | €15k | €13k |
| Cash & bank | 54/58 | €113k | €123k | €107k | €60k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €257k | €261k | €252k | €218k |
| Equity | 10/15 | €205k | €191k | €158k | €146k |
| Contributions / capital | 10/11 | €70k | €70k | €70k | €70k |
| Reserves | 13 | €135k | €121k | €88k | €76k |
| Amounts payable | 17/49 | €52k | €71k | €94k | €72k |
| Amounts payable after one year | 17 | €4k | €12k | €20k | €27k |
| Amounts payable within one year | 42/48 | €48k | €58k | €74k | €45k |
| Trade debts payable within one year | 44 | €24k | €31k | €34k | €11k |
| Income statement | |||||
| Gross operating margin | 9900 | €159k | €124k | €77k | €92k |
| Operating result | 9901 | €22k | €50k | €19k | €41k |
| Financial income | 75 | €60 | €23 | €7 | €3 |
| Financial charges | 65 | €404 | €454 | €580 | €543 |
| Result before taxes | 9903 | €22k | €50k | €19k | €41k |
| Income taxes | 67/77 | €8k | €18k | €6k | €11k |
| Net result for the period | 9904 | €14k | €32k | €13k | €30k |
| Result to be appropriated | 9905 | €14k | €32k | €13k | €30k |
Legal Structure
| NACE primary | Veterinary services(75000) |
| Legal form | Private limited company(610) |
| Incorporation | 22-05-2013 |
| Status | Active |
| Postal code | 3520 |
Establishment units
Sonuwe
since 20132.219.368.908
Real-estate footprint
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71443F0424/00Y002 | Flanders | 898 m² | 1 · 183 m² | 7.4 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2025
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €200kEq €205k ▲7.4%
4 profitable years in a row build equity to €205k.
10-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2021net €32k ▲154%
Operating result €50k, net result €32k, both a record.
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Weakest financial yearnet €13k ▼57.9%
Net result drops to €13k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €150kEq €158k ▲8.7%
2 profitable years in a row build equity to €158k.
23-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
07-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
12-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
05-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
13-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
04-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 4 days late
2016
11-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Veterinary services75000
Names & trade names
| Legal nameNL | SONUWE |
Similar companies
Dierenartsenpraktijk Angélique & Maximilien Van Goethem
BE 0645.735.631 · Geraardsbergen
DUBOIS-MORALES
BE 0831.500.925 · Liège
Dierenartsenpraktijk Ter Turf
BE 0778.406.093 · Berlare
DIERENARTSENPRAKTIJK DE LOVAART
BE 0769.784.377 · Veurne
QUINTINUS
BE 0897.368.675 · Sint-Truiden